Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Dec;50(12):1280–1284. doi: 10.1136/thx.50.12.1280

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens.

H D McIntyre 1, C A Mitchell 1, S D Bowler 1, J G Armstrong 1, J A Wooler 1, D M Cowley 1
PMCID: PMC1021352  PMID: 8553302

Abstract

BACKGROUND--Inhaled glucocorticoid therapy has systemic effects including hypothalamic-pituitary-adrenal (HPA) suppression. The optimal test for detecting these effects has not been defined. METHODS--Timed urine collections and 09.00 hour plasma cortisol levels were obtained from 12 normal volunteers receiving inhaled placebo, beclomethasone (BDP) 800 or 2000 micrograms/day. The 24 hour urine samples were collected as follows: first hour after waking (hour 1), the next two hours after waking (hours 2 and 3), remainder of day, and overnight, with results expressed as urine cortisol/creatinine (UCC) ratios and as hourly cortisol output in the timed collections. Twenty four hour urinary cortisol excretion was also calculated. Medication was blinded and given in random order with a washout period of at least 11 days between each treatment arm. RESULTS--None of the UCC ratios changed with BDP 800 micrograms/day. UCC ratios at hour 1, hour 2 and 3, and overnight, and 24 hour urinary free cortisol excretion were reduced after BDP 2000 micrograms/day, whilst remainder of day UCC ratio and the plasma cortisol level did not change significantly. Cortisol output showed similar changes. In a follow up study BDP 1400 micrograms/day also reduced UCC ratios for the first two hours after waking. CONCLUSIONS--UCC ratios are as sensitive as the more cumbersome 24 hour urinary free cortisol excretion, and more sensitive than single morning plasma cortisol measurements, in detecting the effects of inhaled beclomethasone on the HPA axis.

Full text

PDF
1280

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax. 1990 Oct;45(10):736–739. doi: 10.1136/thx.45.10.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med. 1991 Nov;85(6):501–510. doi: 10.1016/s0954-6111(06)80268-4. [DOI] [PubMed] [Google Scholar]
  3. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med. 1991 Nov;85(6):511–516. doi: 10.1016/s0954-6111(06)80269-6. [DOI] [PubMed] [Google Scholar]
  4. Brown P. H., Greening A. P., Crompton G. K. Hypothalamo-pituitary-adrenal axis suppression in asthmatic adults taking high dose beclomethasone dipropionate. Br J Clin Pract. 1992 Summer;46(2):102–104. [PubMed] [Google Scholar]
  5. Busse W. Asthma in the 1990s. A new approach to therapy. Postgrad Med. 1992 Nov 1;92(6):177-8, 183-6, 189-90. doi: 10.1080/00325481.1992.11701519. [DOI] [PubMed] [Google Scholar]
  6. Contreras L. N., Hane S., Tyrrell J. B. Urinary cortisol in the assessment of pituitary-adrenal function: utility of 24-hour and spot determinations. J Clin Endocrinol Metab. 1986 May;62(5):965–969. doi: 10.1210/jcem-62-5-965. [DOI] [PubMed] [Google Scholar]
  7. Farrer M., Francis A. J., Pearce S. J. Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax. 1990 Oct;45(10):740–742. doi: 10.1136/thx.45.10.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grahnén A., Eckernäs S. A., Brundin R. M., Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol. 1994 Dec;38(6):521–525. doi: 10.1111/j.1365-2125.1994.tb04393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holt P. R., Lowndes D. W., Smithies E., Dixon G. T. The effect of an inhaled steroid on the hypothalamic-pituitary-adrenal axis--which tests should be used? Clin Exp Allergy. 1990 Mar;20(2):145–149. doi: 10.1111/j.1365-2222.1990.tb02659.x. [DOI] [PubMed] [Google Scholar]
  10. Leech J. A., Hodder R. V., Ooi D. S., Gay J. Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis. 1993 Jul;148(1):113–115. doi: 10.1164/ajrccm/148.1.113. [DOI] [PubMed] [Google Scholar]
  11. Prahl P. Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy. 1991 Jan;21(1):145–146. doi: 10.1111/j.1365-2222.1991.tb00817.x. [DOI] [PubMed] [Google Scholar]
  12. Selroos O., Halme M. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax. 1991 Dec;46(12):891–894. doi: 10.1136/thx.46.12.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Teelucksingh S., Padfield P. L., Tibi L., Gough K. J., Holt P. R. Inhaled corticosteroids, bone formation, and osteocalcin. Lancet. 1991 Jul 6;338(8758):60–61. doi: 10.1016/0140-6736(91)90058-w. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES